Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jun;45 Suppl A(Suppl A):A48-56.
doi: 10.1016/j.jvs.2007.02.030.

The chemokine system in arteriogenesis and hind limb ischemia

Paula K Shireman  1
Affiliations
Review

The chemokine system in arteriogenesis and hind limb ischemia

Paula K Shireman. J Vasc Surg. 2007 Jun.

Abstract

Chemokines (chemotactic cytokines) are important in the recruitment of leukocytes to injured tissues and, as such, play a pivotal role in arteriogenesis and the tissue response to ischemia. Hind limb ischemia represents a complex model with arteriogenesis (collateral artery formation) occurring in tissues with normal perfusion while areas exhibiting ischemic necrosis undergo angiogenesis and skeletal muscle regeneration; monocytes and macrophages play an important role in all three of these processes. In addition to leukocyte trafficking, chemokines are produced by and chemokine receptors are present on diverse cell types, including myoblasts, endothelial, and smooth muscle cells. Thus, the chemokine system may have direct effects as well as inflammatory-mediated effects on arteriogenesis, angiogenesis, and skeletal muscle regeneration. This article reviews the complexity of the hind limb ischemia model and the role of the chemokine system in arteriogenesis and the tissue response to ischemia. Special emphasis will be placed on the roles of monocytes/macrophages and CCL2/monocyte chemotactic protein-1 (MCP-1) in these processes.

PubMed Disclaimer

References

    1. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res. 2004;95:858–66. - PubMed
    1. Daley GQ, Goodell MA, Snyder EY. Realistic prospects for stem cell therapeutics. Hematology (Am Soc Hematol Educ Program) 2003:398–418. - PubMed
    1. Montgomery SP, Swiecki CW, Shriver CD. The evaluation of casualties from Operation Iraqi Freedom on return to the continental United States from March to June 2003. J Am Coll Surg. 2005;201:7–12. discussion -3. - PubMed
    1. Marshall TJ., Jr Combat casualty care: the Alpha Surgical Company experience during Operation Iraqi Freedom. Mil Med. 2005;170:469–72. - PubMed
    1. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg. 2002;10:620–30. - PubMed

Publication types

MeSH terms